Literature DB >> 3344181

Growth failure in infants with bronchopulmonary dysplasia: nutrition and elevated resting metabolic expenditure.

S I Kurzner1, M Garg, D B Bautista, D Bader, R J Merritt, D Warburton, T G Keens.   

Abstract

The mechanisms underlying growth failure in infants with bronchopulmonary dysplasia are poorly understood. Thirteen infants with bronchopulmonary dysplasia at 6 months of corrected age and 12 full-term healthy control infants matched for age or size were studied. Resting oxygen consumption was measured during natural sleep, and an estimation of the resting metabolic expenditure by indirect calorimetry was performed. Growth parameters were measured, and a nutritional profile including dietary intake, stool analysis, and serum albumin, cholesterol, glucose, and prealbumin was obtained. Seven of the 13 infants with bronchopulmonary dysplasia had growth failure (defined as length and weight less than the tenth percentile of the Babson growth curves). These infants had lower birth weight, lower gestational age, and a greater number of days spent in supplemental oxygen or on mechanical ventilation. There was no statistical difference between the bronchopulmonary dysplasia-growth failure and bronchopulmonary dysplasia-normal growth infants for dietary intake or stool or serum analyses. However, serum prealbumin showed a significant linear correlation with body weight in infants with bronchopulmonary dysplasia. Resting metabolic expenditure was elevated in infants with bronchopulmonary dysplasia with growth failure and was inversely correlated with body weight in all infants with bronchopulmonary dysplasia. Thus, infants with bronchopulmonary dysplasia and growth failure have increased metabolic demands and decreased prealbumin values suggesting a relative state of protein-calorie malnutrition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3344181

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  16 in total

1.  The EPICure study: growth and associated problems in children born at 25 weeks of gestational age or less.

Authors:  N S Wood; K Costeloe; A T Gibson; E M Hennessy; N Marlow; A R Wilkinson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-11       Impact factor: 5.747

Review 2.  The influence of nutrition on neonatal respiratory muscle function.

Authors:  D C Wilson; G McClure; J A Dodge
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

3.  Bronchopulmonary dysplasia (infantile chronic lung disease).

Authors:  C D Lew
Journal:  West J Med       Date:  1988-10

4.  A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight.

Authors:  L Singer; T Yamashita; L Lilien; M Collin; J Baley
Journal:  Pediatrics       Date:  1997-12       Impact factor: 7.124

Review 5.  Metabolic reprogramming in the pathogenesis of chronic lung diseases, including BPD, COPD, and pulmonary fibrosis.

Authors:  Haifeng Zhao; Phyllis A Dennery; Hongwei Yao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-04       Impact factor: 5.464

6.  Feeding interactions in infants with very low birth weight and bronchopulmonary dysplasia.

Authors:  L T Singer; M Davillier; L Preuss; L Szekely; S Hawkins; T Yamashita; J Baley
Journal:  J Dev Behav Pediatr       Date:  1996-04       Impact factor: 2.225

Review 7.  Emerging Clinical Benefits of New-Generation Fat Emulsions in Preterm Neonates.

Authors:  Gregory Guthrie; Muralidhar Premkumar; Douglas G Burrin
Journal:  Nutr Clin Pract       Date:  2017-01-27       Impact factor: 3.080

8.  Nutrition, insulin-like growth factor-1 and retinopathy of prematurity.

Authors:  Anna-Lena Hård; Lois E Smith; Ann Hellström
Journal:  Semin Fetal Neonatal Med       Date:  2013-02-18       Impact factor: 3.926

9.  Growth and body composition in preterm infants with bronchopulmonary dysplasia.

Authors:  W A Huysman; M de Ridder; N C de Bruin; G van Helmond; N Terpstra; J B Van Goudoever; P J J Sauer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

10.  Growth retardation after dexamethasone administration: assessment by knemometry.

Authors:  A T Gibson; R G Pearse; J K Wales
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.